Analyst Information

 

Joseph Catanzaro, PhD

Sr. Research Analyst

Joseph Catanzaro, PhD

Joe Catanzaro is a director and senior research analyst at Piper Sandler covering biotechnology. Prior to joining Piper Sandler in 2018, Catanzaro spent four years at Cowen, where he also covered biotechnology. Before making the move to Wall Street, Catanzaro worked as a research scientist at Stony Brook University in New York. His work there focused on oncogene-mediated inflammatory signaling and resulted in multiple peer-reviewed publications. Catanzaro received his bachelor’s degree from Binghamton University in biological sciences and earned his Ph.D. in genetics from Stony Brook University.

Universe Coverage:
Healthcare:   Biotechnology
ACHLAchilles Therapeutics, Inc.
AERIAerie Pharmaceuticals, Inc.
AMAGAMAG Pharmaceuticals, Inc.
BMEABiomea Fusion, Inc.
CRDFCardiff Oncology, Inc.
CPRXCatalyst Pharmaceuticals, Inc.
CLVSClovis Oncology, Inc.
CNTBConnect Biopharma Holdings Ltd.
CTMXCytomX Therapeutics, Inc.
EPIXESSA Pharma, Inc.
GBTGlobal Blood Therapeutics, Inc.
GRCLGracell Biotechnologies Inc.
HALOHalozyme Therapeutics, Inc.
HARPHarpoon Therapeutics, Inc.
IMABI-Mab
IMGNImmunoGen, Inc.
IOVAIovance Biotherapeutics, Inc.
KROSKeros Therapeutics, Inc.
LPTXLeap Therapeutics, Inc.
MRKRMarker Therapeutics, Inc.
NKNantKwest, Inc.
NRIXNurix Therapeutics, Inc.
OCULOcular Therapeutix, Inc.
OYSTOyster Point Pharma, Inc.
RAINRain Therapeutics, Inc.
RPTXRepare Therapeutics Inc.
SGENSeagen, Inc.
SNSESensei Biotherapeutics, Inc.